In Hypertension (high blood pressure) Nebawol-AM Tablet is a combination medicine that contains two active ingredients, S-Amlodipine and Nebivolol. Both of the medicines in this combination work to lower blood pressure but in different ways. Together they help to relax blood vessels, reduce heart rate and make it easier for your heart to pump blood around your body. This lowers blood pressure. If your blood pressure is controlled you are less at risk of having a heart attack, stroke or kidney problems. The medicine must be taken regularly as prescribed to be effective. You do not usually feel any direct benefit from taking this medicine, but it works in the long term to keep you well. You should also make appropriate lifestyle changes (such as eating healthy and staying active) to maximize the effectiveness of this medicine.
It is unsafe to consume alcohol with Nebawol
Pregnancy : CONSULT YOUR DOCTOR
AM Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Nebawol
Driving : UNSAFE
AM Tablet may cause side effects which could affect your ability to drive. Nebawol
Kidney : CAUTION
AM Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Nebawol
Liver : CAUTION
AM Tablet should be used with caution in patients with liver disease. Dose adjustment of Nebawol
AM Tablet is started at a lower dose in patients with liver disease and further increased slowly with careful monitoring.
If you miss a dose of Nebawol-AM Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Cipla Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zeelab Pharmacy Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Welkind Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Aristo Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Cadila Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Micro Labs Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: 4Care Lifescience Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Leeford Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Finecure Pharmaceuticals Ltd. || ₹14.5/tablet (25% cheaper)